Resveratrol: From grapevines to mammalian biology

FASEB Journal

Volumn 17, Issue 14, 2003, Pages 1975-1985

  Pervaiz, Shazib ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOKINE; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE SYNTHASE; PHENYLBUTAZONE; PROTEIN KINASE C; PROTEIN P21; PROTEIN P53; RESVERATROL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; BREAST CANCER; CANCER PREVENTION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; DNA BINDING; DRUG ISOLATION; DRUG STRUCTURE; EDEMA; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEART PROTECTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIVER FIBROSIS; LIVER PROTECTION; MEDICINAL PLANT; NEUROPROTECTION; NONHUMAN; PLANT ROOT; POLYGONUM; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION; TRADITIONAL MEDICINE; TRANSCRIPTION REGULATION; WINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CARDIOTONIC AGENTS; GENE EXPRESSION; MAMMALS; NEUROPROTECTIVE AGENTS; STILBENES; TRANSCRIPTION FACTORS; WINE;

ANIMALIA; MAMMALIA; POLYGONUM;

EID: 0242695672     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.03-0168rev     Document Type: Review

References (133)

1. Soleas, G. J., Diamandis, E. P., and Goldberg, D. M. (1997) Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30, 91-113
2. Nonomura, S., Kanagawa, H., and Makimoto, A. (1963) Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jo-kon. (Polygonum Capsidatum-SIEB et ZUCC). Yakugaku Zasshi 83, 988-990
3. Kubo, M., Kimurta, Y., Shin, H., Haneda, T., Tani, T., and Namba, K. (1981) Studies on the anti-fungal substances of crude drug (II). On the roots of Polygonum Capsidatum Sieb et Zucc. (Polygonaceae). Shoyakugaku Zasshi 35, 58-61
4. Langcake, P., and Pryce, R. J. (1976) The production of resveratrol by Vitis vinifera and other members of the vitaceae as a response to infection or injury. Physiol. Plant Pathol. 9, 77-86
5. Siemann, E. H., and Creasy, L. L. (1992) Concentration of the phytoalexin resveratrol in wine. An. J. Eno. Vitic. 43, 49-52
6. Sato, M., Maulik, N., and Das, D. K. (2002) Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann. N.Y. Acad. Sci. 957, 122-135
7. Kopp, P. (1998) Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur. J. Endocrinol. 138, 619-620
8. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220
9. Haworth, R. S., and Avkiran, M. (2001) Inhibition of protein kinase D by resveratrol. Biochem. Pharmaco. 62, 1647-1651
10. Tou, J., and Urbizo, C. (2001) Resveratrol inhibits the formation of phosphatidic acid and diglyceride in chemotactic peptide- or phorbol ester-stimulated human neutrophils. Cell. Signal. 13, 191-197
11. Mgbonyebi, O. P., Russo, J., and Russo, I. H. (1998) Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol. 12, 865-869
12. Pozo-Guisado, E., Alvarez-Barrientos, A., Mulero-Navarro, S., Santiago-Josefat, B., and Fernandez-Salguero, P. M. (2002) The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol. 64, 1375-1386
13. Ragione, F. D., Cucciolla, V., Borriello, A., Pietra, V. D., Racioppi, L., Soldati, G., Manna, C., Galletti, P., and Zappia, V. (1998) Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem. Biophys. Res. Commun. 250, 53-58
14. Mizutani, K., Ikeda, K., Kawai, Y., and Yamori, Y. (1998) Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 253, 859-863
15. Manna, S. K., Mukhopadhyay, A., and Aggarwal, B. B. (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164, 6509-6519
16. Clement, M. V., Hirpara, J. L., Chawdhury, S. H., and Pervaiz, S. (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996-1002
17. Huang, C., Ma, W. Y., Goranson, A., and Dong, Z. (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20, 237-242
18. Hsieh, T. C., and Wu, J. M. (1999) Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res. 249, 109-115
19. Rotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotillo, D., de Gaetano, G., Evangelista, V., and Cerletti, C. (1998) Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br. J. Pharmacol. 123, 1691-1699
20. Wadsworth, T. L., and Koop, D. R. (1999) Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol. 57, 941-949
21. Lu, R., and Serrero, G. (1999) Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J. Cell. Physiol. 179, 297-304
22. Mitchell, S. H., Zhu, W., and Young, C. Y. (1999) Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res. 59, 5892-5895
23. Langcake, P., and Pryce, R. J. (1977) The production of resveratrol and the viniferins by grapevines in response to ultraviolet irradiation. Phytochemistry 16, 1193-1196
24. Langcake, P., and Pryce, R.J. (1977) Oxidative dimerization of 4-hydroxystilbenes in vitro: Production of a grapevine phytoalexin mimic. J. Chem. Soc. Commun. 1412, 208-210
25. Jeandet, P., Douillet-Breuil, A. C., Bessis, R., Debord, S., Sbaghi, M., and Adrian, M. (2002) Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. J. Agric. Food Chem. 50, 2731-2741
26. Jeandet, P., Bessis, R., Sbaghi, M., and Meunier, P. (1995) Production of the phytoalexin resveratrol by grape berries as a response to Botrytis attack under natural conditions. J. Phytopathol. 143, 135-139
27. Hoos, G., and Blaich, R. (1988) Metabolism of stilbene phytoalexin in grapevines: oxidation of resveratrol in single cell culture. Vitis 27, 1-12
28. Lamuela-Raventos, R. M., Romero-Perez, A. I., Waterhouse, A. L., and de la Torre-Boronat, M. C. (1995) Direct HPLC analysis of cis and trans-resveratrol and piecid isomers in Spanish red Vitis vinifera wines. J. Agric. Food Chem. 43, 281-283
29. Soleas, G.J., Yan, J., and Goldberg, D. M. (2001) Measurement of trans-resveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection. Methods Enzymol. 335, 130-145
30. Jeandet, P., Bessis, R., Sbaghi, M., Meunier, P., and Trollat, P. (1995) Resveratrol content of wines of different ages: relationship with fungal disease pressure in the vineyard. Am. J. Enol. Vitic 46, 1-4
31. Ebel, J. (1986) Phytoalexin synthesis: the biochemical analysis of the induction process. Annu. Rev. Phytopath. 24, 235-264
32. Hain, R., Bieseler, B., Kindl, H., Schroder, G., and Stocker, R. (1990) Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol. Biol. 15, 325-335
33. Hain, R., Reif, H. J., Krause, E., Langebartels, R., Kindl, H., Vornam, B., Wiese, W., Schmelzer, E., Schreier, P. H., Stocker, R. H., et al. (1993) Disease resistance results from foreign phytoalexin expression in a novel plant. Nature (London) 361, 153-156
34. Halliwell, B., and Gutteridge, J. M. C. (1999) Free Radicals in Biology and Medicine, Clarendon Press, Oxford, England
35. Packer, L. (1992) Interactions among anti-oxidants in health and diseases: vitamin E and its redox cycle. Proc. Soc. Exp. Biol. Med. 200, 271-276
36. Esterbauer, H., Gebicki, J., Puhl, H., and Jurgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13, 341-390
37. Steinberg, D., Parsatharathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increases its atherogenicity. N. Engl. J. Med. 320, 915-924
38. Whitehead, T. P., Robinson, D., Allaway, S., Syms, J., and Hale, A. (1995) Effect of red wine ingestion on the antioxidant capacity of serum. Clin. Chem. 41, 32-35
39. Fuhrman, B., Lavy, A., and Aviram, M. (1995) Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am. J. Clin. Nutr. 61, 549-554
40. Miller, N.J., and Rice-Evans, C. A. (1995) Antioxidant activity of resveratrol in red wine. Clin. Chem. 41, 1789
41. Frankel, E. N., Waterhouse, A. L., and Kinsella, J. E. (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 341, 1103-1104
42. Goldberg, D. M., Hahn, S. E., and Parkes, J. G. (1995) Beyond alcohol: beverage consumption and cardiovascular mortality. Clin. Chim. Acta 237, 155-187
43. Wilson, T., Knight, T. J., Beitz, D. C., Lewis, D. S., and Engen, R. L. (1996) Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits. Life Sci. 59, L15-L21
44. Sun, A. Y., Chen, Y. M., James-Kracke, M., Wixom, P., and Cheng, Y. (1997) Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem. Res. 22, 1187-1192
45. Draczynska-Lusiak, B., Doung, A., and Sun, A. Y. (1998) Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease. Mol. Chem. Neuropathol. 33, 139-148
46. Kawada, N., Seki, S., Inoue, M., and Kuroki, T. (1998) Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 27, 1265-1274
47. Martinez, J., and Moreno, J. J. (2000) Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 59, 865-870
48. Cerutti, P. A. (1985) Prooxidant states and tumor promotion. Science 227, 375-381
49. Hung, L. M., Chen, J. K., Huang, S. S., Lee, R. S., and Su, M. J. (2000) Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47, 549-555
50. Hattori, R., Otani, H., Maulik, N., and Das, D. K. (2002) Pharmacological preconditioning with resveratrol: role of nitric oxide. Am. J. Physiol. 282, H1988-H1995
51. Orsini, F., Pelizzoni, F., Verotta, L., Aburjai, T., and Rogers, C. B. (1997) Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-beta-D-glucopyranoside and related compounds. J. Nat. Prod. 60, 1082-1087
52. Olas, B., Wachowicz, B., Szewczuk, J., Saluk-Juszczak, J., and Kaca, W. (2001) The effect of resveratrol on the platelet secretory process induced by endotoxin and thrombin. Microbios 105, 7-13
53. Fremont, L. (2000) Biological effects of resveratrol. Life Sci. 66, 663-673
54. Cuendet, M., and Pezzuto, J. M. (2000) The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol. Drug Interact. 17, 109-157
55. Gierse, J. K., Hauser, S. D., Creely, D. P., Koboldt, C., Rangwala, S. H., Isakson, P. C., and Seibert, K. (1995) Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem. J. 305, 479-484
56. Kimura, Y., Okuda, H., and Kubo, M. (1995) Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. J. Ethnopharmacol. 45, 131-139
57. Gusman, J., Malonne, H., and Atassi, G. (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22, 1111-1117
58. Kimura, Y., Okuda, H., and Arichi, S. (1985) Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim. Biophys. Acta 834, 275-278
59. MacCarrone, M., Lorenzon, T., Guerrieri, P., and Agro, A. F. (1999) Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem. 265, 27-34
60. Ahmad, N., Adhami, V. M., Afaq, F., Feyes, D. K., and Mukhtar, H. (2001) Resveratrol causes WAF-1/p21-mediated G (1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin. Cancer Res. 7, 1466-1473
61. Ding, X. Z., and Adrian, T. E. (2002) Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 25, e71-e76
62. Ferry-Dumazet, H., Garnier, O., Mamani-Matsuda, M., Vercauteren, J., Belloc, F., Billiard, C., Dupouy, M., Thiolat, D., Kolb, J. P., Marit, G., et al. (2002) Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23, 1327-1333
63. Morris, G. Z., Williams, R. L., Elliott, M. S., and Beebe, S. J. (2002) Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells. Prostate 52, 319-329
64. Gentilli, M., Mazoit, J. X., Bouaziz, H., Fletcher, D., Casper, R. F., Benhamou, D., and Savouret, J. F. (2001) Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Sci. 68, 1317-1321
65. Tsai, S. H., Lin-Shiau, S. Y., and Lin, J. K. (1999) Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol. 126, 673-680
66. Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., and Dannenberg, A. J. (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273, 21875-21882
67. Harlan, J. M. (1987) Neutrophil-mediated vascular injury. Acta Med. Scand. Suppl. 715, 123-129
68. Halliwell, B. (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344, 721-724
69. Hsieh, T. C., Juan, G., Darzynkiewicz, Z., and Wu, J. M. (1999) Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59, 2596-2601
70. Totani, L., Piccoli, A., Pellegrini, G., Di Santo, A., and Lorenzet, R. (1994) Polymorphonuclear leukocytes enhance release of growth factors by cultured endothelial cells. Arterioscler. Thromb. 14, 125-132
71. Arnaout, M. A. (1990) Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75, 1037-1050
72. Miagkov, A. V., Kovalenko, D. V., Brown, C. E., Didsbury, J. R., Cogswell, J. P., Stimpson, S. A., Baldwin, A. S., and Makarov, S. S. (1998) NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad, Sci. USA 95, 13859-13864
73. Suganuma, M., Okabe, S., Marino, M. W., Sakai, A., Sueoka, E., and Fujiki, H. (1999) Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res. 59, 4516-4518
74. Pahl, H. L. (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866
75. Holmes-McNary, M., and Baldwin, A. S., Jr. (2000) Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res. 60, 3477-3483
76. Ashikawa, K., Majumdar, S., Banerjee, S., Bharti, A. C., Shishodia, S., and Aggarwal, B. B. (2002) Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J. Immunol. 169, 6490-6497
77. Karin, M., Liu, Z., and Zandi, E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246
78. Karin, M., and Delhase, M. (1998) JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? Proc. Natl. Acad. Sci. USA 95, 9067-9069
79. von Knethen, A., Callsen, D., and Brune, B. (1999) Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J. Immunol. 163, 2858-2866
80. Hwang, D., Jang, B. C., Yu, G., and Boudreau, M. (1997) Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. Biochem. Pharmacol. 54, 87-96
81. Sato, H., and Seiki, M. (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405
82. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D., and Maniatis, T. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9, 899-909
83. Banerjee, S., Bueso-Ramos, C., and Aggarwal, B. B. (2002) Suppression of 7,12-dimethylbenz (a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62, 4945-4954
84. Culig, Z., Klocker, H., Bartsch, G., and Hobisch, A. (2002) Androgen receptors in prostate cancer. Endocr. Relat. Cancer 9, 155-170
85. Hsieh, T. C., and Wu, J. M. (2000) Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism. Anticancer Res. 20, 225-228
86. Basly, J. P., Marre-Fournier, F., Le Bail, J. C., Habrioux, G., and Chulia, A. J. (2000) Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci. 66, 769-777
87. Gehm, B. D., McAndrews, J. M., Chien, P.Y., and Jameson, J. L. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 94, 14138-14143
88. Stahl, S., Chun, T. Y., and Gray, W. G. (1998) Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line. Toxicol. Appl. Pharmacol. 152, 41-48
89. Turner, R. T., Evans, G. L., Zhang, M., Maran, A., and Sibonga, J. D. (1999) Is resveratrol an estrogen agonist in growing rats? Endocrinology 140, 50-54
90. Ashby, J., Tinwell, H., Pennie, W., Brooks, A. N., Lefevre, P. A., Beresford, N., and Sumpter, J. P. (1999) Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects. J. Appl. Toxicol. 19, 39-45
91. Freyberger, A., Hartmann, E., Hildebrand, H., and Krotlinger, F. (2001) Differential response of immature rat uterine tissue to ethinylestradiol and the red wine constituent resveratrol. Arch. Toxicol. 74, 709-715
92. Hayashi, S., Watanabe, J., Nakachi, K., Eguchi, H., Gotoh, O., and Kawajiri, K. (1994) Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15, 801-806
93. Rowlands, J. C., and Gustafsson, J. A. (1997) Aryl hydrocarbon receptor-mediated signal transduction. Crit. Rev. Toxicol. 27, 109-134
94. Ciolino, H. P., Daschner, P. J., and Yeh, G. C. (1998) Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res. 58, 5707-5712
95. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42
96. Murray, G. I. (2000) The role of cytochrome P450 in tumour development and progression and its potential in therapy. J. Pathol. 192, 419-426
97. Ciolino, H. P., and Yeh, G. C. (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol. 56, 760-767
98. Casper, R. F., Quesne, M., Rogers, I. M., Shirota, T., Jolivet, A., Milgrom, E., and Savouret, J. F. (1999) Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol. Pharmacol. 56, 784-790
99. Chang, T. K., Chen, J., and Lee, W. B. (2001) Differential inhibition and inactivation of human CYP1 enzymes by transresveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther. 299, 874-882
100. Chan, W. K., and Delucchi, A. B. (2000) Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4. Life Sci. 67, 3103-3112
101. Bhat, K. P., and Pezzuto, J. M. (2002) Cancer chemopreventive activity of resveratrol. Ann. N.Y. Acad. Sci. 957, 210-229
102. Steele, R. J., Thompson, A. M., Hall, P. A., and Lane, D. P. (1998) The p53 tumour suppressor gene. Br. J. Surg. 85, 1460-1467
103. Flatt, P. M., Polyak, K., Tang, L. J., Scatena, C. D., Westfall, M. D., Rubinstein, L. A., Yu, J., Kinzler, K. W., Vogelstein, B., Hill, D. E., et al. (2000) p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Cancer Lett. 156, 63-72
104. Hussain, S. P., Hollstein, M. H., and Harris, C. C. (2000) p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment. Ann. N.Y. Acad. Sci. 919, 79-85
105. She, Q. B., Bode, A. M., Ma, W. Y., Chen, N. Y., and Dong, Z. (2001) Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61, 1604-1610
106. Soleas, G.J., Diamandis, E. P., and Goldberg, D. M. (2001) The world of resveratrol. Adv. Exp. Med. Biol. 492, 159-182
107. Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D., and Weinstein, I. B. (2002) Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8, 893-903
108. Pervaiz, S. (2001) Resveratrol-from the bottle to the bedside? Leuk. Lymphoma 40, 491-498
109. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., and Guittet, O. (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421, 277-279
110. Grunewald, R., Kantarjian, H., Du, M., Faucher, K., Tarassoff, P., and Plunkett, W. (1992) Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study. J. Clin. Oncol. 10, 406-413
111. Tsan, M. F., White, J. E., Maheshwari, J. G., and Chikkappa, G. (2002) Anti-leukemia effect of resveratrol. Leuk. Lymphoma 43, 983-987
112. Schneider, Y., Vincent, F., Duranton, B., Badolo, L., Gosse, F., Bergmann, C., Seiler, N., and Raul, F. (2000) Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 158, 85-91
113. Bernhard, D., Tinhofer, I., Tonko, M., Hubl, H., Ausserlechner, M. J., Greil, R., Kofler, R., and Csordas, A. (2000) Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ. 7, 834-842
114. Hsieh, T. C., Burfeind, P., Laud, K., Backer, J. M., Traganos, F., Darzynkiewicz, Z., and Wu, J. M. (1999) Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int. J. Oncol. 15, 245-252
115. Carbo, N., Costelli, P., Baccino, F. M., Lopez-Soriano, F.J., and Argiles, J. M. (1999) Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun. 254, 739-743
116. Hengartner, M. O. (2000) The biochemistry of apoptosis. Nature (London) 407, 770-776
117. Thornberry, N. A. (1998) Caspases: key mediators of apoptosis. Chem. Biol. 5, 97-103
118. Pervaiz, S., Seyed, M. A., Hirpara, J. L., Clement, M. V., and Loh, K. W. (1999) Purified photoproducts of merocyanine 540 trigger cytochrome C release and caspase 8-dependent apoptosis in human leukemia and melanoma cells. Blood 93, 4096-4108
119. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K. M., Krammer, P. H., and Peter, M. E. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687
120. Korsmeyer, S. J. (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer. Res. 59, 1693s-1700s
121. Green, D., and Kroemer, G. (1998) The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8, 267-271
122. Dorrie, J., Gerauer, H., Wachter, Y., and Zunino, S. J. (2001) Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer. Res. 61, 4731-4739
123. Mahyar-Roemer, M., Katsen, A., Mestres, P., and Roemer, K. (2001) Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. Int. J. Cancer 94, 615-622
124. Roman, V., Billard, C., Kern, C., Ferry-Dumazet, H., Izard, J. C., Mohammad, R., Mossalayi, D. M., and Kolb, J. P. (2002) Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br. J. Haematol. 117, 842-851
125. Tinhofer, I., Bernhard, D., Senfter, M., Anether, G., Loeffler, M., Kroemer, G., Kofler, R., Csordas, A., and Greil, R. (2001) Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J. 15, 1613-1615
126. Tessitore, L., Davit, A., Sarotto, I., and Caderni, G. (2000) Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21 (CIP) expression. Carcinogenesis 21, 1619-1622
127. Mahyar-Roemer, M., Kohler, H., and Roemer, K. (2002) Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells. BMC Cancer 2, 27
128. Micheau, O., Solary, E., Hamman, A., Martin, F., and Dimanche-Boitrel, M. T. (1997) Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J. Natl. Cancer Inst. 89, 783-789
129. Tsan, M. F., White, J. E., Maheshwari, J. G., Bremner, T. A., and Sacco, J. (2000) Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. Br. J. Haematol. 109, 405-412
130. Clement, M. V., Ponton, A., and Pervaiz, S. (1998) Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett. 440, 13-18
131. Pervaiz, S., and Clement, M. V. (2002) A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification. Biochem. Biophys. Res. Commun. 290, 1145-1150
132. Clement, M. V., and Stamenkovic, I. (1996) Superoxide anion is a natural inhibitor of FAS-mediated cell death. EMBO J. 15, 216-225
133. Pervaiz, S., Ramalingam, J. K., Hirpara, J. L., and Clement, M. V. (1999) Superoxide anion inhibits drug-induced tumor cell death. FEBS Lett. 459, 343-348